This streamlined approach not only accelerates the drug discovery pipeline but also improves the overall success rate of identifying viable drug targets. The AI-Powered Target Identification Service ...

Another company involved in using AI to repurpose failed drugs – as well as drugs that have already been approved – is ...

Biotech company Valo Health and AI healthcare firm nference have entered into a multi-year partnership to leverage AI and ...

Among the investors is GlaxoSmithKline, which is teaming up with the biotech startup in a multi-target ... rare disease drug discovery. The founders of Vesalius Therapeutics say AI and machine ...

Learn how AI-driven TechBio is revolutionizing biotech in our exclusive interview with Bullfrog AI CEO Vin Singh.

A Boston drug discovery company that uses AI has hit unicorn valuation. It uses transformer diffusion models, which its CEO ...

Valo Health, Inc. ("Valo"), a biotechnology company focused on transforming the drug discovery and development process using ...

Tiny Michigan biotech startup CircNova has raised a $3.3 million seed round for its technology that uses AI to target “circular ... for how to use it with AI drug discovery.

Insilico Medicine, an AI drug discovery company based in Hong Kong and Boston, has joined the unicorn club after raising $110 million in a funding round led by Hong Kong-headquartered asset ...